1997
DOI: 10.1159/000127230
|View full text |Cite
|
Sign up to set email alerts
|

Vasopressin Acts in the Subfornical Organ to Decrease Blood Pressure

Abstract: In addition to its traditional role as a circulating vasoactive peptide, vasopressin (VP) has been shown to play significant roles in central cardiovascular processing. The recent description of VP receptors within the subfomical organ (SFO) has suggested this circumventricular organ (CVO) as a potential locus for feedback actions of circulating VP on the brain. The well-established anatomical connections between SFO and hypothalamic autonomic control centers provide further arguments in support of such a view… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
25
0
1

Year Published

1999
1999
2021
2021

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 29 publications
(26 citation statements)
references
References 18 publications
(27 reference statements)
0
25
0
1
Order By: Relevance
“…Of particular interest is the subfornical projection to the hypothalamic paraventricular and supraoptic nuclei which may influence directly the neuroendocrine activity of vasopressinergic neurons, as well as modify autonomic output through descending paraventricular projections to the spinal cord. The sensitivity of subfornical neurons to circulating AVP suggests that the subfornical organ represents an essential structure in a feedback loop through which circulating AVP influences cardiovascular control [26]. Neurons of the area postrema connect to the adjacent nucleus of the solitary tract, a structure involved in baroreflex and cardiovascular regulation [27, 28], control of fluid homeostasis, food intake and development of conditioned taste aversions associated with nausea [29].…”
Section: Discussionmentioning
confidence: 99%
“…Of particular interest is the subfornical projection to the hypothalamic paraventricular and supraoptic nuclei which may influence directly the neuroendocrine activity of vasopressinergic neurons, as well as modify autonomic output through descending paraventricular projections to the spinal cord. The sensitivity of subfornical neurons to circulating AVP suggests that the subfornical organ represents an essential structure in a feedback loop through which circulating AVP influences cardiovascular control [26]. Neurons of the area postrema connect to the adjacent nucleus of the solitary tract, a structure involved in baroreflex and cardiovascular regulation [27, 28], control of fluid homeostasis, food intake and development of conditioned taste aversions associated with nausea [29].…”
Section: Discussionmentioning
confidence: 99%
“…Other regulatory peptides known for effects on the cardiovascular system that have been shown to influence blood pressure as a result of actions in the SFO include vasopressin (116,137) and atrial natriuretic peptide (105). In addition, the reproductive hormone, relaxin (82), the orexigenic and arousal neuropeptide, orexin (118), and the adipose tissue-derived hormone, leptin (P. Smith and A. Ferguson, unpublished observation) have also been shown to influence blood pressure when microinjected into the SFO.…”
Section: Anatomical Features Of the Sfomentioning
confidence: 99%
“…They play important roles in sensing circulating signals from the periphery and sending such information to control centres behind the blood-brain barrier responsible for the regulation of autonomic responses [25]. The SFO has been shown to play critical roles in the control of blood pressure by integrating signals from a wide range of circulating neuropeptides including vasopressin [26], [27], orexin [28], apelin [29], angiotensin II [30], [31], atrial natriuretic peptide [32], and leptin [33]. It has also recently been shown that both NAPDH oxidases and superoxide both play a critical role in the SFO regarding angiotensin II induced hypertension, with site specific knockdown in SFO reducing hypertension induced by angiotensin II infusion [34], [35].…”
Section: Introductionmentioning
confidence: 99%